Company news
Apimeds Pharmaceuticals Us, Inc. (AMEX:APUS) news
Every Apimeds Pharmaceuticals Us, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
D. Boral Capital Acted as Sole Bookrunner to Apimeds Pharmaceuticals US, Inc. (NYSE:APUS) in connection with its $13.5 Million Initial Pu...
September 14, 2026
Apimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and Lōkahi Therapeutics to Advan...
May 5, 2026
Apimeds Pharmaceuticals US : Annual Report for Fiscal Year Ending December 31, 2025 (Form 10-K)
May 4, 2026
Apimeds Pharmaceuticals US Inc. Announces Material Breach of Merger Agreement by Inscobee Inc. (KS:006490) and Apimeds Inc.; Prepares Fil...
March 24, 2026
Apimeds Pharmaceuticals and Lōkahi Therapeutics Announce FDA Type C Meeting Scheduled for LT‑100 (Apitox)
February 11, 2026
Apimeds Pharmaceuticals and MindWave Innovations Announce Closing of $100MM PIPE Financing and Activation of 1,000 Bitcoin to Power AI-Dr...
December 10, 2025
Apimeds and MindWave Announce Merger, Integrating Biotech Growth with AI-Driven Digital Treasury Yield Generation Backed by $100M PIPE
December 1, 2025
Apimeds Brings ai² Futures Lab™ to the Palouse — Partnering with the University of Idaho to Shape the Future of Biotech Innovation
November 10, 2025
Apimeds Pharmaceuticals says "I love my Ducks" with new ai² Futures Lab™ Program collaboration with the University of Oregon’s Lundquist ...
October 14, 2025
Apimeds Expands ai² Future Labs Program to Include University of San Diego Students in Biotech Business Development
September 15, 2025
Apimeds Welcomes FDA Draft Guidance as Catalyst for Advancing Apitox Non-Opioid Pain Program
September 11, 2025
Apimeds Pharmaceuticals US, Inc. Partners with University of Alabama to Advance Biotech Business Development via ai² Future Labs
August 25, 2025
Apimeds Expands Leadership Team with Dr. Susan Kramer to Lead Product Development and Brian Peters to Lead its ai² Division
July 15, 2025
Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering
May 12, 2025
Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering
May 8, 2025